Table 3. Characteristics of baseline contraceptive use for women included in models assessing the relationship between method discontinuation and the Method Information Index (MII) or Facility Quality, respectively.
| MII to Discontinuation
Models (N = 1,033) |
Facility Quality to
Discontinuation Models (N = 938) |
|||
|---|---|---|---|---|
| Baseline Contraceptive Use | n | % | n | % |
| Method | ||||
| Implant | 120 | 11.6% | 119 | 12.7% |
| IUD | 73 | 7.1% | 70 | 7.5% |
| Injectable | 611 | 59.2% | 586 | 62.5% |
| Oral Contraceptive | 196 | 19.0% | 138 | 14.7% |
| Condoms | 33 | 3.2% | 25 | 2.7% |
| Episode Type (3YR) 1 | ||||
| Discontinuer | 216 | 20.9% | 198 | 21.1% |
| Switcher | 54 | 5.2% | 46 | 4.9% |
| Continuer | 763 | 73.9% | 684 | 74.0% |
| Source of FP Method | ||||
| Public Hospital | 464 | 44.9% | 464 | 49.5% |
| Other Public Facility | 191 | 18.5% | 191 | 20.4% |
| Private Hospital | 241 | 23.3% | 241 | 25.7% |
| Other Private Facility | 137 | 13.7% | 42 | 4.5% |
| MII Score | ||||
| 0 | 162 | 15.7% | 140 | 14.9% |
| 1 | 217 | 21.0% | 184 | 19.6% |
| 2 | 81 | 7.9% | 77 | 8.2% |
| 3 | 573 | 55.5% | 537 | 57.3% |
| MII by Question | ||||
| Informed of side effects | 669 | 64.8% | 627 | 66.9% |
| Told how to resolve problems | 611 | 59.2% | 572 | 62.0% |
| Informed of other methods | 818 | 79.2% | 750 | 80.0% |
1Classification of the baseline episode at 3 years. Discontinuers are women who discontinued their method within 3 years for any reason, without switching to a new method – including discontinuation while in need, discontinuation while not in need, and method failure.
IUD – intrauterine device, FP – Family planning